Research Nester published a report titled Positron Emission Tomography Scanners Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global positron emission tomography scanners in terms of market segmentation application, product type, detector type, end user and by region. 

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global positron emission tomography scanners market is anticipated to grow with a CAGR of ~5% over the forecast period, i.e., 2022 – 2031. The market is segmented by end user into hospitals, diagnostic centers, PET centers, and research institutes. Out of these segments, the end user segment is projected to garner the largest revenue by the end of 2031. The segment is projected to grow on the back of a higher number of specialized medical professionals and rising awareness of the early diagnosis of cancer. For instance, it was noticed that about 2,050,000 clinical PET scans were performed in 2019 solely in the USA.

The global positron emission tomography scanners market is estimated to garner significant revenue by the end of 2031. Skyrocketing cases of cancer across the globe are estimated to hike the growth of the market over the forecast period. Based on the data provided by the American Cancer Society, 1.9 million of new cancer cases were diagnosed in 2022 while in the US 609,360 cancer deaths were caused by cancer in the similar year. Furthermore, a higher prevalence of Huntington’s disease across the globe is also expected to push the growth of the market over the forecast period. For instance, around 40,000 Americans were observed to be suffering from Huntington’s disease annually. 

Geographically, the global positron emission tomography scanners market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Out of these, the market in North America is projected to capture the largest market share by the end of 2031. The rising healthcare expenditure is expected to the expansion of the market in the region. A recent study found that the population of the United States spent 16% of its gross domestic product (GDP) on health care.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

ALSO READ  How did Katarzyna Kobro become interested in sculpture?

     Increasing Prevalence of Breast Cancer Worldwide to Drive Market Growth 

     As per the World Health Organization, 2.3 million women worldwide suffered from breast cancer in 2020, causing 685 000 deaths. The number of women diagnosed with breast cancer reached 7.8 million by 2020.

The increasing prevalence of breast cancer among women is expected to drive market growth. Women worldwide suffer from a high rate of mortality and morbidity from breast cancer. Breast cancer diagnosis and treatment have been made possible by imaging biomarkers. In the last few years, several studies and products have been published regarding PET-based imaging of breast cancer.  

However, high cost of product coupled with Low life expectancy of scanners to operate as key restraint to the growth of global positron emission tomography scanners market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global positron emission tomography scanners which includes company profiling of General Electric Company, General de Equipment for Medical Imaging, S.A., Koninklijke Philips N.V., Neusoft Corporation, Siemens Healthcare GmbH, Segami Corporation, Spectrum Dynamics Medical, Inc., Hitachi, Ltd., Cerveau Technologies, Inc., and Radiology Oncology System, Inc.The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global positron emission tomography scanners market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.